Prostate Cancer
An Open-Label, Phase 1/1b Study of ORIC-944 as a Single Agent or in Combination with an Androgen Receptor Pathway Inhibitor in Patients with Metastatic Prostate Cancer (ORIC-944-01)
- Details
ClinicalTrials.gov ID:
NCT05413421
Diagnosis Type:
NA
USOR Number:
- Address
,
P: